New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
07:33 EDTVIVOMeridian Bioscience reports Q1 adjusted EPS 20c, consensus 19c
Reports Q1 revenue $45.4M consensus $44.34M.
News For VIVO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2015
08:02 EDTVIVOMeridian Bioscience reaffirms FY15 EPS view 85c-91c, consensus 86c
Subscribe for More Information
08:02 EDTVIVOMeridian Bioscience reports Q3 EPS 22c, consensus 22c
Reports Q3 revenue $48.2M, consensus $48.6M.
July 20, 2015
09:26 EDTVIVOMeridican says illumigene receives FDA clearance
Meridian Bioscience announced that it has received FDA clearance for two new molecular assays for the detection of Herpes Simplex Virus Type 1 and Type 2, to be run on its illumigene molecular platform. The illumigene HSV 1&2 assays, launched earlier this year in Europe, are now available immediately in the U.S.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use